Castleview Partners’s Smith & Wesson SWBI Stock Holding History

Castleview Partners’s Portfolio SWBI Stock Details SWBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-70	Closed	-$862	–	728
2023 Q1	$862	Hold	70	–	–	﹤0.01%	620
2022 Q4	$607	Hold	70	–	–	﹤0.01%	580
2022 Q3	$1K	Sell	70 -130	-65%	-$1.72K	﹤0.01%	598
2022 Q2	$2.63K	Buy	200 +77	+63%	+$1.12K	﹤0.01%	614
2022 Q1	$1K	Sell	123 -2,066	-94%	-$34.7K	﹤0.01%	684
2021 Q4	$123	Buy	+2,189	New	+$45.2K	﹤0.01%	759
2021 Q2	$4K	Buy	+123	New	+$2.58K	﹤0.01%	813

Other funds holding SWBI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Punch Card Management Winter Park, Florida $271M AUM 11.49% 1-Year Est. Return

Castleview Partners's SWBI Position: Q2 2023 in Review

Castleview Partners sold out of Smith & Wesson (SWBI) in Q2 2023, closing a stake of 70 shares — an estimated $862 sold.

Castleview Partners first reported a position in SWBI in Q2 2021 and held it in 7 quarters. The position peaked at $4K in Q2 2021. 164 funds tracked by Wall St. Rank hold SWBI as of Q2 2023.

Castleview Partners reported no remaining Smith & Wesson position as of Q2 2023 after selling out during the quarter.
Castleview Partners sold 70 Smith & Wesson shares in Q2 2023, an estimated $862.
Castleview Partners first reported a position in Smith & Wesson in Q2 2021 and held it in 7 quarters.
Castleview Partners's Smith & Wesson position peaked at $4K in Q2 2021.
164 funds tracked by Wall St. Rank held Smith & Wesson as of Q2 2023.

Based on Castleview Partners's 13F filing for Q2 2023, filed 15 Aug 2023.